Riggs Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-56
Closed -$10.1K – 324
2025
Q2
$10.1K Buy
56
+6
+12% +$1.04K ﹤0.01% 328
2025
Q1
$8.46K Hold
50
– – ﹤0.01% 277
2024
Q4
$7.55K Hold
50
– – ﹤0.01% 276
2024
Q3
$7.76K Hold
50
– – ﹤0.01% 273
2024
Q2
$6.84K Hold
50
– – ﹤0.01% 282
2024
Q1
$6.66K Hold
50
– – ﹤0.01% 265
2023
Q4
$6.89K Hold
50
– – ﹤0.01% 272
2023
Q3
$6.09K Hold
50
– – ﹤0.01% 277
2023
Q2
$7.03K Hold
50
– – ﹤0.01% 263
2023
Q1
$7.07K Buy
+50
New +$7.15K ﹤0.01% 244

Other funds holding DGX

Riggs Asset Management's DGX Position: Q3 2025 in Review

Riggs Asset Management sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 56 shares — an estimated $10.1K sold.

Riggs Asset Management first reported a position in DGX in Q1 2023 and held it in 10 quarters. The position peaked at $10.1K in Q2 2025. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Riggs Asset Management reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 56 Quest Diagnostics shares in Q3 2025, an estimated $10.1K.
  • Riggs Asset Management first reported a position in Quest Diagnostics in Q1 2023 and held it in 10 quarters.
  • Riggs Asset Management's Quest Diagnostics position peaked at $10.1K in Q2 2025.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.